<乌鸦传媒>Low-Dose DOAC Valuable in Afib After Age 80 Randomized trial suggests benefit on par with warfarin in younger groups Aug 30, 2020
<乌鸦传媒>Impressive Results With Early-Rhythm Control in AFib Results from EAST-AFNET 4 trial "should and will change practice," expert says Aug 29, 2020
<乌鸦传媒>Novel Tx Turns in Favorable Performance in Obstructive HCM Mavacamten tackles underlying pathophysiology of hypertrophic cardiomyopathy Aug 29, 2020
<乌鸦传媒>Second SGLT2 Drug Scores for HFrEF, Regardless of Diabetes Status EMPEROR-Reduced trial "exceptionally concordant" with DAPA-HF results Aug 28, 2020
<乌鸦传媒>Post-MI Survival Better With ICD for Some, Troubled Trial Suggests Potential benefit in STEMI survivors with severe LV dysfunction, other risk factors soon after PCI Sep 04, 2019
<乌鸦传媒>Precision Medicine Lowers DAPT Bleeds in STEMI Trial also hits noninferiority mark for adverse cardiac events Sep 03, 2019
<乌鸦传媒>SYNTAX at 10 Years: Bypass vs PCI Still a Toss-Up Overall But CABG beats stenting for important subgroups Sep 03, 2019
<乌鸦传媒>MITRA-FR Inches in Line With COAPT at 2 Years Despite Contradictory Findings More evidence that the two trials are more concordant than previously thought Sep 02, 2019
<乌鸦传媒>Bariatric Surgery Tied to Better Cardiometabolic Health Down the Road Improvements beyond risk factor reduction in patients with T2D and obesity Sep 02, 2019
<乌鸦传媒>Antiplatelets Go Head-to-Head in ACS, With Unexpected Result Assumption that ticagrelor would be superior upended in ISAR-REACT 5 Sep 02, 2019
<乌鸦传媒>Big Cuts in LDL Possible With Twice-Yearly Injections siRNA may make for a more convenient lipid-lowering therapy for patients Sep 02, 2019
<乌鸦传媒>Dapagliflozin Benefits HFrEF Outcomes, Even Without Diabetes DAPA-HF trial affirms similar benefit to diabetes drug regardless of type 2 diabetes status Sep 01, 2019
<乌鸦传媒>Risk-Based Thresholds for hs-Troponin I Safely Speed MI Rule-Out HISTORIC suggests benefit to patients, clinicians Sep 01, 2019
<乌鸦传媒>Extended DAPT with Brilinta: No Benefit for Stable CAD in T2D Substudy in those with prior PCI might identify group where bleeding tradeoff is worthwhile Sep 01, 2019
<乌鸦传媒>COMPLETE Revascularization Gets Its Win for Hard Outcomes Investigators obtain missing piece of the puzzle Sep 01, 2019
<乌鸦传媒>Entresto Signals Expansion Into 'Gray Zone' of HFpEF PARAGON-HF may have missed overall, but HF docs see reason for hope Sep 01, 2019
<乌鸦传媒>Drive LDL as Low as Possible, ESC Says New guideline emphasizes more intensive reduction across risk groups Aug 31, 2019
<乌鸦传媒>ESC: Evidence Grows for HFpEF as Microvascular Disease Studies on exact mechanisms, potential targets still needed Aug 29, 2018
<乌鸦传媒>ESC: DCB Works for De Novo Stenoses in Small Coronary Vessels Established for in-stent restenosis, DCBs make their way to native coronary arteries Aug 28, 2018
<乌鸦传媒>ESC: Oral Antibiotics Safe for Stable Endocarditis Switching after a period of IV antibiotics didn't raise event rates in POET trial Aug 28, 2018
<乌鸦传媒>ESC: ACS Outcomes the Same for High-Sensitivity vs Standard Troponin Tests No reduction in later events with more sensitive assay Aug 28, 2018
<乌鸦传媒>ESC: PURE Buries Controversy, Advocates for 'Balanced Diet' But dairy and red meat levels still differ from guidelines Aug 28, 2018
<乌鸦传媒>ESC: Interatrial Shunting Safe in HFpEF, Pivotal Trial to Come Device eases left-sided filling pressure, but to what clinical significance? Aug 27, 2018
<乌鸦传媒>ESC: MI Redefined in International Guidelines Fourth "Universal Definition of Myocardial Infarction" issued Aug 27, 2018
<乌鸦传媒>ESC: Tafamidis Cuts Deaths, Admissions in TTR Cardiac Amyloidosis Plus clear advantage seen in 6-minute walk test Aug 27, 2018
<乌鸦传媒>ESC: Xarelto Fails to Change Outcomes in Heart Failure No death or hospitalization reduction seen in COMMANDER-HF Aug 27, 2018
<乌鸦传媒>ESC: Short DAPT with Ticagrelor Doesn't Improve Outcomes Antiplatelet strategy safe, but misses superiority to standard DAPT after stenting Aug 27, 2018
<乌鸦传媒>ESC: MitraClip Fails in Functional Mitral Regurgitation No impact on hard outcomes in MITRA-FR randomized trial Aug 27, 2018
<乌鸦传媒>ESC: Aspirin Holds Little Net Benefit for Primary CV Prevention 'No compelling evidence' emerges in two randomized trials Aug 26, 2018
<乌鸦传媒>ESC: Omega-3 Supplements No Better Than Olive Oil for CV Risk 1-g dose disappoints in ASCEND trial Aug 26, 2018
<乌鸦传媒>ESC: Weight-Loss Drug Clears Major CV Hurdle Trial also shows modest reduction in new cases of diabetes Aug 26, 2018
<乌鸦传媒>ESC: Rivaroxaban Doesn't Prevent VTE after Acute Illness Efficacy shown in prior trial is lost, but safety gained in this setting Aug 26, 2018
<乌鸦传媒>ESC: Restrictive Transfusion Deemed Safe in Cardiac Surgery Patients Restrictive strategy superior in those ages ≥75, according to TRICS III trial Aug 26, 2018
<乌鸦传媒>ESC: Telemonitoring of HF Cuts Admissions, Mortality Remote patient management program works in German trial Aug 25, 2018
<乌鸦传媒>ESC: CTA for Stable Chest Pain Prevents More MIs Long Term Better than stress ECG as first-line test, SCOT-HEART investigators say Aug 25, 2018
<乌鸦传媒>ESC: Top Videos from This Year's Meeting Highlights include CANTOS history and a Houston cardiologist's take on the flood Sep 01, 2017
<乌鸦传媒>ESC: Yusuf, Lloyd-Jones Square Off Over Diet Guidelines PURE not going to change AHA fat recommendations? Aug 30, 2017
<乌鸦传媒>ESC: 1-Hour NSTEMI Rule-Out 'Very Safe' in Study ESC's algorithm validated with high negative predictive values Aug 30, 2017
